文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

2018年美国肌萎缩侧索硬化症的患病率

Prevalence of amyotrophic lateral sclerosis in the United States, 2018.

作者信息

Mehta Paul, Raymond Jaime, Zhang Yuzi, Punjani Reshma, Han Moon, Larson Theodore, Muravov Oleg, Lyles Robert H, Horton D Kevin

机构信息

Office of Innovation and Analytics, National ALS Registry, Agency for Toxic Substances and Disease Registry/Centers for Disease Control and Prevention, Atlanta, GA, USA and.

Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, GA, USA.

出版信息

Amyotroph Lateral Scler Frontotemporal Degener. 2023 Aug 21:1-7. doi: 10.1080/21678421.2023.2245858.


DOI:10.1080/21678421.2023.2245858
PMID:37602649
Abstract

OBJECTIVE: To estimate prevalent ALS cases in the United States for calendar year 2018. METHODS: The National ALS Registry (Registry) compiled data from national administrative databases (from the Centers for Medicare and Medicaid Services, the Veterans Health Administration, and the Veterans Benefits Administration) and enrollment data voluntarily submitted through a web portal (www.cdc.gov/als). We used log-linear capture-recapture (CRC) model-based methodology to estimate the number of cases not ascertained by the Registry. RESULTS: The Registry identified 21,655 cases of ALS in 2018, with an age-adjusted prevalence of 6.6 per 100,000 U.S. population. When CRC methods were used, an estimated 29,824 cases were identified, for an adjusted prevalence of 9.1 per 100,000 U.S. population. The demographics of cases of ALS did not change from previous year's reports. ALS continues to impact Whites, males, and persons over 50 years of age more so than other comparison groups. The results from the present report suggest case ascertainment for the Registry has improved, with the estimate of missing prevalent cases decreasing from 44% in 2017 to 27% in in 2018. DISCUSSION: Consistent with previous estimates that used CRC, ALS prevalence in the United States is about 29,824 cases per year.

摘要

目的:估算2018日历年美国肌萎缩侧索硬化症(ALS)的流行病例数。 方法:国家ALS注册中心(注册中心)从国家行政数据库(来自医疗保险和医疗补助服务中心、退伍军人健康管理局和退伍军人福利管理局)收集数据,并通过门户网站(www.cdc.gov/als)自愿提交的登记数据。我们使用基于对数线性捕获再捕获(CRC)模型的方法来估算注册中心未确定的病例数。 结果:注册中心在2018年确定了21,655例ALS病例,年龄调整后的患病率为每10万美国人口6.6例。当使用CRC方法时,确定了约29,824例病例,调整后的患病率为每10万美国人口9.1例。ALS病例的人口统计学特征与上一年度报告相比没有变化。与其他对照组相比,ALS对白人、男性和50岁以上人群的影响仍然更大。本报告结果表明,注册中心的病例确诊情况有所改善,未确诊的流行病例估计数从2017年的44%降至2018年的27%。 讨论:与之前使用CRC的估计一致,美国ALS的患病率约为每年29,824例。

相似文献

[1]
Prevalence of amyotrophic lateral sclerosis in the United States, 2018.

Amyotroph Lateral Scler Frontotemporal Degener. 2023-8-21

[2]
Prevalence of Amyotrophic Lateral Sclerosis - United States, 2012-2013.

MMWR Surveill Summ. 2016-8-5

[3]
Prevalence of amyotrophic lateral sclerosis in the United States using established and novel methodologies, 2017.

Amyotroph Lateral Scler Frontotemporal Degener. 2023-2

[4]
Prevalence of amyotrophic lateral sclerosis - United States, 2010-2011.

MMWR Suppl. 2014-7-25

[5]
Prevalence of amyotrophic lateral sclerosis (ALS), United States, 2016.

Amyotroph Lateral Scler Frontotemporal Degener. 2022-5

[6]
Incidence of amyotrophic lateral sclerosis in the United States, 2014-2016.

Amyotroph Lateral Scler Frontotemporal Degener. 2022-8

[7]
Evaluation of the Completeness of ALS Case Ascertainment in the US National ALS Registry: Application of the Capture-Recapture Method.

Neuroepidemiology. 2022

[8]
Estimation of the Prevalence of Amyotrophic Lateral Sclerosis in the United States Using National Administrative Healthcare Data from 2002 to 2004 and Capture-Recapture Methodology.

Neuroepidemiology. 2018-8-9

[9]
Prevalence of ALS in all 50 states in the United States, data from the National ALS Registry, 2011-2018.

Amyotroph Lateral Scler Frontotemporal Degener. 2024-11

[10]
Preliminary Results of National Amyotrophic Lateral Sclerosis (ALS) Registry Risk Factor Survey Data.

PLoS One. 2016-4-28

引用本文的文献

[1]
Racial and ethnic disparities in ALS: a longitudinal electronic health records study.

Ther Adv Neurol Disord. 2025-9-1

[2]
Metal-Induced Genotoxic Events: Possible Distinction Between Sporadic and Familial ALS.

Toxics. 2025-6-12

[3]
Phenotypic Characterization of ALS-Causing SOD1 Mutations Affecting Polypeptide Length.

Hum Mutat. 2025-6-16

[4]
Assessment of the glymphatic dysfunction in amyotrophic lateral sclerosis using the diffusion tensor imaging along the perivascular spaces index: a pilot study.

Front Aging Neurosci. 2025-5-13

[5]
Evaluation and Bias Analysis of Large Language Models in Generating Synthetic Electronic Health Records: Comparative Study.

J Med Internet Res. 2025-5-12

[6]
Characteristics and Motivations of People With Amyotrophic Lateral Sclerosis Who Pursue Medical Aid in Dying in California.

Neurol Clin Pract. 2025-6

[7]
Sleep and Arousal Hubs and Ferromagnetic Ultrafine Particulate Matter and Nanoparticle Motion Under Electromagnetic Fields: Neurodegeneration, Sleep Disorders, Orexinergic Neurons, and Air Pollution in Young Urbanites.

Toxics. 2025-4-8

[8]
Home-Based Tele-tDCS in Amyotrophic Lateral Sclerosis: Feasibility, Safety, and Preliminary Efficacy.

Ann Clin Transl Neurol. 2025-5

[9]
Head Injury and Amyotrophic Lateral Sclerosis: Population-Based Study from the National ALS Registry.

Brain Sci. 2025-1-31

[10]
Biological and therapeutic significance of targeting NLRP3 inflammasome in the brain and the current efforts to develop brain-penetrant inhibitors.

Adv Pharmacol. 2025

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索